These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 12144683)

  • 21. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pleomorphic Undifferentiated Uterine Sarcoma in a Young Patient Presenting With Elevated Beta-hCG and Rare Variants of Benign Leiomyoma: A Case Report and Review of the Literature.
    Krishnan V; Sauthier P; Provencher D; Rahimi K
    Int J Gynecol Pathol; 2020 Jul; 39(4):362-366. PubMed ID: 31033798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI of uterine leiomyosarcoma.
    Pattani SJ; Kier R; Deal R; Luchansky E
    Magn Reson Imaging; 1995; 13(2):331-3. PubMed ID: 7739376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MVP immunohistochemistry is a useful adjunct in distinguishing leiomyosarcoma from leiomyoma and leiomyoma with bizarre nuclei.
    Lintel NJ; Luebker SA; Lele SM; Koepsell SA
    Hum Pathol; 2018 Mar; 73():122-127. PubMed ID: 29307622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diffusion-Weighted Imaging for Differentiating Uterine Leiomyosarcoma From Degenerated Leiomyoma.
    Li HM; Liu J; Qiang JW; Zhang H; Zhang GF; Ma F
    J Comput Assist Tomogr; 2017; 41(4):599-606. PubMed ID: 27997438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential diagnostic biomarkers: differential expression of LMP2/β1i and cyclin B1 in human uterine leiomyosarcoma.
    Hayashi T; Horiuchi A; Sano K; Hiraoka N; Ichimura T; Sudo T; Ishiko O; Yaegashi N; Aburatani H; Konishi I
    Tumori; 2014; 100(4):99e-106e. PubMed ID: 25296613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fascin expression in uterine smooth muscle tumors.
    Kefeli M; Yildiz L; Kaya FC; Aydin O; Kandemir B
    Int J Gynecol Pathol; 2009 Jul; 28(4):328-33. PubMed ID: 19483633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic Value of Preoperative CA125, LDH and HE4 for Leiomyosarcoma of the Female Reproductive System.
    Zhang F; Liu Y; Quan Q; Meng Y; Mu X
    Cancer Manag Res; 2021; 13():4657-4664. PubMed ID: 34163240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and prognostic value of lactate dehydrogenase-A and -D subunits in human uterine myoma and uterine sarcoma.
    Song KJ; Yu XN; Lv T; Chen YL; Diao YC; Liu SL; Wang YK; Yao Q
    Medicine (Baltimore); 2018 Apr; 97(14):e0268. PubMed ID: 29620641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An immunohistochemical analysis of stathmin 1 expression in uterine smooth muscle tumors: differential expression in leiomyosarcomas and leiomyomas.
    Allen MM; Douds JJ; Liang SX; Desouki MM; Parkash V; Fadare O
    Int J Clin Exp Pathol; 2015; 8(3):2795-801. PubMed ID: 26045786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy and confidence of Gd-EOB-DTPA enhanced MRI and diffusion-weighted imaging alone and in combination for the diagnosis of liver metastases.
    Donati OF; Fischer MA; Chuck N; Hunziker R; Weishaupt D; Reiner CS
    Eur J Radiol; 2013 May; 82(5):822-8. PubMed ID: 23287713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images.
    Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC
    PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical application.
    Vadasz B; Felicelli C; Feng Y; Yin P; Zhang Q; Bulun S; Wei JJ
    Hum Pathol; 2023 Apr; 134():85-91. PubMed ID: 36549601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine leiomyoma versus leiomyosarcoma: a new attempt at differential diagnosis based on their cellular characteristics.
    Watanabe K; Suzuki T
    Histopathology; 2006 Apr; 48(5):563-8. PubMed ID: 16623782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preoperative clinical characteristics scoring system for differentiating uterine leiomyosarcoma from fibroid.
    Zhang G; Yu X; Zhu L; Fan Q; Shi H; Lang J
    BMC Cancer; 2020 Jun; 20(1):514. PubMed ID: 32493236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
    Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
    Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MR imaging findings of unusual leiomyoma and malignant uterine myometrial tumors: what the radiologist should know.
    Fujii S; Mukuda N; Ochiai R; Yunaga H; Murakami A; Gonda T; Kishimoto M; Yamaji D; Ishibashi M
    Jpn J Radiol; 2021 Jun; 39(6):527-539. PubMed ID: 33517507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased LDH5/LDH1 ratio in preoperative diagnosis of uterine sarcoma with inconclusive MRI and LDH total activity but suggestive CT scan: a case report.
    Mollo A; Raffone A; Travaglino A; Di Cello A; Saccone G; Zullo F; De Placido G
    BMC Womens Health; 2018 Oct; 18(1):169. PubMed ID: 30340636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic Resonance Imaging Grading System for Preoperative Diagnosis of Leiomyomas and Uterine Smooth Muscle Tumors.
    Suzuki Y; Wada S; Nakajima A; Fukushi Y; Hayashi M; Matsuda T; Asano R; Sakurai Y; Noguchi H; Shinohara T; Sato C; Fujino T
    J Minim Invasive Gynecol; 2018; 25(3):507-513. PubMed ID: 29079462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
    Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
    Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.